Albireo to Participate at Upcoming Investor Conferences
yahoo.com
news
2022-06-02 20:30:00

Albireo Pharma, Inc.

BOSTON, June 02, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive Officer will be presenting at the following investor conferences:



William Blair 42nd Annual Growth Stock Conference

Tuesday, June 7 at 8 a.m. CT/9:00 a.m. ET

Jefferies Healthcare Conference

Wednesday, June 8 at 10:00 a.m. ET



The webcasts of the presentations will be available on-demand on the Albireo Investors page ir.
